BLUEBIRD BIO INC (BLUE) Earnings History & Surprises
NASDAQ:BLUE • US09609G2093
4.97 USD
0 (0%)
At close: May 30, 2025
4.99 USD
+0.02 (+0.4%)
After Hours: 5/30/2025, 8:00:01 PM
Past quarterly earnings results for BLUEBIRD BIO INC (BLUE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateAug 12, 2025
PeriodQ2 / 2025
EPS Estimate-$2.64
Revenue Estimate46.512M
Last Reported
Release DateMay 14, 2025
PeriodQ1 / 2025
EPS Reported-$2.98
EPS Surprise 25.85%
Revenue Surprise 0.87%
Beat Rate
56%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | -2.98 | -4.02 | 25.85% | 58.61% | 38.712M | 38.378M | 0.87% | 108.43% |
| Q4 2024 | -2.95 | -6.10 | 51.60% | 81.09% | 38.521M | 27.617M | 39.48% | 391.72% |
| Q3 2024 | -6.20 | -7.43 | 16.57% | 53.03% | 10.612M | 18.41M | -42.36% | -14.36% |
| Q2 2024 | -8.40 | -8.50 | 1.18% | 37.31% | 16.101M | 24.739M | -34.92% | 133.69% |
| Q1 2024 | -7.20 | -8.99 | 19.91% | -271.43% | 18.573M | 19.942M | -6.86% | 680.05% |
| Q4 2023 | -15.60 | -13.50 | -15.51% | 3.70% | 7.834M | 17.012M | -53.95% | 7,734.00% |
| Q3 2023 | -13.20 | -13.77 | 4.12% | 29.79% | 12.392M | 13.579M | -8.74% | 12,292.00% |
| Q2 2023 | -13.40 | -14.60 | 8.20% | 47.24% | 6.89M | 12.177M | -43.42% | 359.33% |
| Q1 2023 | 4.20 | -7.55 | 155.64% | 112.65% | 2.381M | 18.558M | -87.17% | 25.32% |
| Q4 2022 | -16.20 | -8.89 | -82.14% | 62.15% | 100K | 13.805M | -99.28% | -93.75% |
| Q3 2022 | -18.80 | -22.79 | 17.50% | 70.25% | 100K | 1.023M | -90.22% | -90.00% |
| Q2 2022 | -25.40 | -25.22 | -0.71% | 62.97% | 1.5M | 694.243K | 116.06% | 1,400.00% |
| Q1 2022 | -33.20 | -28.41 | -16.85% | 45.93% | 1.9M | 747.997K | 154.01% | 111.11% |
| Q4 2021 | -42.80 | -38.45 | -11.30% | 28.90% | 1.6M | 5.185M | -69.14% | 100.67% |
| Q3 2021 | -63.20 | -52.82 | -19.64% | -7.48% | 1M | 38.349M | -97.39% | -94.82% |
| Q2 2021 | -68.60 | -66.36 | -3.38% | -852.78% | 100K | 18.309M | -99.45% | -99.95% |
| Q1 2021 | -61.40 | -61.37 | -0.05% | 15.66% | 900K | 11.597M | -92.24% | -95.89% |
| Q4 2020 | -60.20 | -59.51 | -1.16% | - | -240M | 14.946M | -1,705.78% | - |
| Q3 2020 | -58.80 | -62.23 | 5.51% | - | 19.3M | 24.026M | -19.67% | - |
| Q2 2020 | -7.20 | -52.96 | 86.41% | - | 198.9M | 68.032M | 192.36% | - |
| Q1 2020 | -72.80 | -81.82 | 11.03% | - | 21.9M | 7.701M | 184.38% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
23.80%
Max EPS beat (4)
51.60%
Min EPS beat (4)
1.18%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-9.23%
Max Revenue beat (4)
39.48%
Min Revenue beat (4)
-42.36%
Analysis
In the last 4 quarters, BLUE has consistently beaten EPS estimates in all releases
BLUE has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, BLUE has beaten the EPS estimates by 23.8% on average.
In the last 4 quarters, BLUE reported -9.2% below the revenue estimates on average.
BLUEBIRD BIO INC / BLUE Earnings FAQ
What is the most recent earnings date for BLUE stock?
BLUEBIRD BIO INC (BLUE) last reported earnings on 5/14/2025.
Can you provide information on whether BLUEBIRD BIO INC beat earnings estimates in the last quarter?
BLUEBIRD BIO INC (BLUE) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does BLUE stock beat earnings estimates?
In the last 4 quarters, BLUEBIRD BIO INC (BLUE) has beaten EPS estimates in 4 out of 4 releases.